Described herein are compounds having general formula (1), wherein groups R
1
, R
2
, R
3
, Ar
1
, Ar
2
, Ar
3
, X, Y, p and n are as defined in the specification, and a salt, solvate and hydrate thereof. Such compounds inhibit glycine transport (or reuptake) via the GlyT-1 transporter, or are precursors (for example, pro-drugs) of such compounds and, thus, are useful in the treatment of schizophrenia, as well as other CNS-related disorders such as dementia, Alzheimer's disease, attention deficit disorder and depression.
本文描述的化合物具有一般式(1),其中基团R1、R2、R3、Ar1、Ar2、Ar3、X、Y、p和n如规范中所定义,并且其盐、溶剂合物和
水合物。这些化合物通过GlyT-1转运蛋白抑制甘
氨酸的转运(或重新摄取),或者是这些化合物的前体(例如,前药),因此在治疗精神分裂症以及其他中枢神经系统相关疾病,如痴呆症、阿尔茨海默病、注意力缺陷障碍和抑郁症方面是有用的。